• NIFTY 11,661.85  (0.65% )  
  • SENSEX 39,298.38  (0.63%)  
  • USDINR 71.21  (-0.06%)  
  • GOLD 38,084.00  (-0.29%)
  • Go
Corporate Information
Sun Pharma launches ready-to-infuse INFUGEM in US market
(08 Apr 2019) Back
Sun Pharmaceutical Industries announced that INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the first chemotherapy product that comes in a premixed, ready-to-infuse formulation, was approved by the U.S. Food and Drug Administration (FDA) in July 2018 in combination with other drugs for the treatment of breast, ovarian, non-small cell lung cancers, and as a single agent for the treatment of pancreatic cancer.